YOCON at the 2026 Cell Therapy Industry Conference

During the 2026 Cell Therapy Industry Conference, YOCON presented its nine product lines covering the upstream of cell therapy.

In the technical session, the team shared field data on applying serum-free systems to large-scale NK cell expansion, including fold expansion, final viability and functional phenotype trends.

Cooperation discussions for MSC exosome and iPSC technical services were also opened at the booth.